
Effect of different polymers on avanafil–β-cyclodextrin inclusion complex: in vitro and in vivo evaluation
Keywords: PDE5, phosphodiesterase enzyme type 5; FDA, Food and Drug Administration; CD, cyclodextrin; PEG, polyethylene glycol; PVP, polyvinyl pyrrolidone; HPMC, hydroxypropylmethyl cellulose; HEC, hydroxyethyl cellulose; HPLC, high performance liquid chromatograph